In marked contrast, Doxy-activated Tet-HER1-CAR-T-cell therapy only slightly suppressed MDA-MB-468-Erl-R tumors and erlotinib treatment alone at the tested dosage had a minimal suppressive effect on tumor growth (Fig. 6F and G and Fig. S19). Here, EGFR is linked to neoplasm.